TREVIA 50MG TAB

TREVIA 50MG TAB contains sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor used to help manage type 2 diabetes mellitus. It works by increasing insulin release and decreasing glucagon levels when blood sugar is elevated, helping to control blood glucose levels. Each tablet contains 50mg of sitagliptin phosphate monohydrate. TREVIA is typically used as monotherapy or in combination with other antidiabetic agents. It is suitable for adults with type 2 diabetes and may help improve glycemic control when used as directed by a healthcare professional. Always consult your doctor before use and follow the prescribed dosage instructions carefully.